Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial.
Peey Sei KokPatrick M FordeBrett HughesZhuoxin SunChris BrownSuresh RamalingamAlistair CookWillem Joost LesterhuisSonia YipKen O'ByrneNick PavlakisJulie BrahmerValsamo AnagnostouKate FordKaren FitzpatrickAlison BrickerMichelle M CumminsMartin StocklerAnna K Nowaknull nullPublished in: BMJ open (2022)
ClinicalTrials.gov Identifier: NCT04334759 ACTRN 12620001199909.